Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancer.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 3, p. 202, doi. 10.1007/s11912-007-0022-3
- By:
- Publication type:
- Article
Works matching IS 15233790 AND DT 2007 AND VI 9 AND IP 3
Results: 12
1
2
Immunotherapy for prostate cancer.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 3, p. 226, doi. 10.1007/s11912-007-0026-z
- By:
- Publication type:
- Article
3
The role of high-intensity focused ultrasound in prostate cancer.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 3, p. 222, doi. 10.1007/s11912-007-0025-0
- By:
- Publication type:
- Article
4
The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 3, p. 213, doi. 10.1007/s11912-007-0024-1
- By:
- Publication type:
- Article
5
Clinical trials in metastatic hormone-refractory prostate cancer: Improving docetaxel therapy by targeting bone-related growth factors.
- Published in:
- 2007
- By:
- Publication type:
- Report
6
Shifting from clinical to biologic indicators of prognosis after resection of hepatic colorectal metastases.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 3, p. 193, doi. 10.1007/s11912-007-0021-4
- By:
- Publication type:
- Article
7
Combined-modality therapy for esophageal and gastroesophageal junction cancers.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 3, p. 184, doi. 10.1007/s11912-007-0020-5
- By:
- Publication type:
- Article
8
New developments in the treatment of gastrointestinal neuroendocrine tumors.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 3, p. 177, doi. 10.1007/s11912-007-0019-y
- By:
- Publication type:
- Article
9
Pancreatic cancer: An update.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 3, p. 170, doi. 10.1007/s11912-007-0018-z
- By:
- Publication type:
- Article
10
Recent advances in therapy for gastrointestinal stromal tumors.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 3, p. 165, doi. 10.1007/s11912-007-0017-0
- By:
- Publication type:
- Article
11
Web alert.
- Published in:
- 2007
- Publication type:
- Editorial
12
Use of progression-free survival as a valid endpoint in phase II cancer clinical trials.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 3, p. 159, doi. 10.1007/s11912-007-0015-2
- By:
- Publication type:
- Article